Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
160 studies found for:    Open Studies | "Heparin"
Show Display Options
Rank Status Study
21 Recruiting Investigating Different Anticoagulants for Renal Replacement Therapy
Condition: Acute Kidney Injury
Interventions: Drug: Heparin;   Drug: Citrate
22 Recruiting LMWH Infusion as Anticoagulation for Home HD
Condition: Endstage Renal Disease
Interventions: Drug: Nadroparin;   Drug: Unfractionated heparin
23 Recruiting Radial Artery Occlusion After Endovascular Procedure
Condition: Embolism and Thrombosis of the Radial Artery
Intervention: Drug: heparin
24 Not yet recruiting Heparinized Islets in Clinical Islet Transplantation
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Transplantation of islets with heparin coating
25 Recruiting Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions
Conditions: Cardiac Surgery;   Bleeding;   Transfusion;   Protamine Sulfate;   Heparin
Intervention: Other: HeProCalc algorithm
26 Not yet recruiting Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment
Condition: Lipoprotein Lipase Deficiency
Intervention: Drug: Heparin
27 Not yet recruiting Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
Conditions: Post Polypectomy Bleeding in Anticoagulated Patients;   Gastrointestinal Hemorrhage
Interventions: Drug: Warfarin;   Drug: LMW Heparin
28 Not yet recruiting Randomized Anticoagulation Trial in Opcab (RATIO)
Condition: Ischemic Heart Disease
Intervention: Drug: Heparin
29 Not yet recruiting Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI
Condition: Coronary Disease
Interventions: Drug: bivalirudin;   Drug: Heparin
30 Recruiting A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing CABG (STEPS)
Condition: Coronary Artery Disease
Interventions: Device: SOMVC001 Vascular Conduit Solution;   Other: Standard of care Heparin-dosed saline
31 Recruiting Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.
Condition: Pulmonary Embolism
Intervention: Drug: Dabigatran
32 Recruiting Pharmacogenomics of Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Procedure: Blood Draw
33 Recruiting Hemostatic Complications in Hematopoietic Stem Cell Transplantation
Condition: Hemostatic Disorders
Intervention: Drug: thrombopoietin, interleukin-11, heparin,
34 Recruiting Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Conditions: Venous Thrombosis;   Neoplasms
Intervention: Drug: Heparin, Low-Molecular-Weight
35 Recruiting Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
Condition: Sterility
Intervention: Drug: Bemiparin sodium
36 Recruiting Argatroban in Critically Ill Patients With Heparin Resistance
Condition: Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
Intervention: Drug: Argatroban
37 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin
38 Recruiting ODSH + ICE Chemotherapy in Pediatric Solid Tumors
Conditions: Recurrent Solid Tumor;   Refractory Solid Tumor;   Sarcoma;   Wilms' Tumor;   Neuroblastoma
Intervention: Drug: ODSH
39 Recruiting Thoracic Surgery Extended Low-Molecular Weight Heparin VTE Prophylaxis--Pilot Trial
Conditions: Venous Thromboembolism;   Lung Neoplasms;   Pulmonary Embolism
Interventions: Drug: LMWH: Dalteparin;   Other: Placebo
40 Recruiting Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Conditions: Critical Ill Patients;   Patients Needing Continuous Renal Replacement Therapy
Interventions: Device: AN69ST hemofilter;   Device: AN69 hemofilter

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.